Prof. Severine Vermeire (KU Leuven / UZ Leuven): «In the future, gut bacteria may be used to help identify PSC patients with a more or
less aggressive disease, or patients that may benefit from microbiota - based
therapies, such as fecal microbiota transplantation or targeted pre - and probiotics.»